Drive DeVilbiss Healthcare insists it will enter 2019 with an expanded UK manufacturing facility that can meet increased demand from customers at home and abroad after completing a “major realignment” of its production facilities.
The company has made a substantial financial investment in its Halifax-based operations in order to enhance its day-to-day manufacturing procedures and cope with a growing order book.
Earlier this year, sister company Drive DeVilbiss France transferred its bed production from Vietnam to its site in West Yorkshire.
Drive DeVilbiss said the purpose of the move was to help support its increasing demand and improve the quality of its products.
This decision has impacted positively on the firm’s Halifax-based production facility with significant financial investment on machinery and equipment, the introduction of a cell-based assembly to streamline manufacture as well as the launch of an upskill training programme.
Alongside this, a new three shift working pattern has been structured in order to create additional jobs ready to meet future manufacture and delivery demands and expected sales growth.
The production of the new bed for its sister company expands a manufacturing portfolio that includes the IQ, Innov8 and Solite bed ranges that it continues to manufacture in West Yorkshire.
A Drive DeVilbiss spokesperson said: “With increasing demand to manufacture products for UK sales, our expanding export order book and the high volume of acute bed manufacturing to service the rental market, our UK production facilities will play a significant role in supporting our customers’ requirements across the UK and international markets moving forward.”